<!doctype html>
 <html>
 <head>
 <meta charset='UTF-8'>
 <title>Bio</title>
 <style type='text/css'>
 	.in-bio-photo{
     width: 200px;
     height: 200px;
     border-radius: 100%;
     text-align: center;
 }	
 </style>
 </head>
  <body>
 <p style='text-align: center'><img class='in-bio-photo' src='/dtm/bios/2022/magee.jpg' alt='speaker-headshot'/></p><p style='text-align: center; font-weight: bold;'>Michelle F. Magee, MD<br/>Georgetown University; MedStar Diabetes Institute, Washington, District of Columbia</p><p>
 --Diabetes health services researcher, clinician and educator. <br/>--Trained at the Royal College of Surgeons in Ireland and the George Washington University.<br/>--Professor of Medicine, Georgetown University School of Medicine<br/>--Director, MedStar Health Diabetes Institute in Washington, DC and Maryland <br/>--In addition, Dr Magee is a member of the Association of Diabetes Care &amp; Education Specialists Board of Directors and the 2022 National Standards for DSMES Writing Group. She also has served or serves on national committees for the ADA, the Endocrine Society, the American Heart Association, and the Society of Hospital Medicine.</p><p>Relevant to today&rsquo;s topic, Dr Magee has had a career long interest and expertise in innovative evidence-based strategies for the delivery of diabetes clinical care and education among diverse adults with diabetes, including the use of glucose monitoring technologies.<br/></p>
 </body>
 </html>